Affordable and innovative medicines

The mission of our Generics business is to make healthcare more affordable and to improve access to important medicines through the provision of high-quality small-molecule generics to patients all around the world. Currently, our products are approved by regulatory agencies in around 100 countries and marketed through strategic partnerships and - in dedicated areas - through direct sales.

read more about our Generics business

The ambition of our Biopharmaceuticals business is to be best-in-class or first-in-class with novel products based on new molecular entities. Our growing portfolio reflects our focus and commitment to bringing medicines to patients with a high unmet medical need, notably in oncology and autoimmune diseases.

read more about our Biopharmaceuticals business
     Share this page